Kimia Biosciences (BOM:530313) Debt-to-Asset : 0.00 (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Debt-to-Asset?

Kimia Biosciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₹0.00 Mil. Kimia Biosciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₹0.00 Mil.

Kimia Biosciences Debt-to-Asset Historical Data

The historical data trend for Kimia Biosciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Debt-to-Asset Chart

Kimia Biosciences Annual Data

Trend

Debt-to-Asset

Kimia Biosciences Semi-Annual Data

Debt-to-Asset

Competitive Comparison of Kimia Biosciences's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Debt-to-Asset falls into.

Kimia Biosciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Kimia Biosciences's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

Kimia Biosciences's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

Kimia Biosciences (BOM:530313) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Kimia Biosciences Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Kimia Biosciences (BOM:530313) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034

Website

https://www.kimiabiosciences.com

Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines